Disposition of 1000 shares by Eric Schoen of Cassava Sciences at 33.0 subject to Rule 16b-3

SAVA Stock  USD 2.75  0.06  2.23%   
About 60% of Cassava Sciences' investor base is looking to short. The analysis of overall sentiment of trading Cassava Sciences stock suggests that many investors are alarmed at this time. The current market sentiment, together with Cassava Sciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Cassava Sciences stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Cassava Sciences Officer: Chief Financial Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Read at macroaxis.com
Disposition of 1000 common stock warrant at 33.0 of Cassava Sciences by Eric Schoen on 17th of April 2024. This event was filed by Cassava Sciences with SEC on 2024-04-17. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

Cassava Sciences' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Cassava Sciences' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Cassava Sciences Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Cassava Sciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Cassava Sciences Maximum Pain Price Across March 21st 2025 Option Contracts

Cassava Sciences' options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Cassava Sciences close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Cassava Sciences' options.

Cassava Sciences Fundamental Analysis

We analyze Cassava Sciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cassava Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cassava Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Valuation

Current Valuation Comparative Analysis

Cassava Sciences is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Cassava Sciences Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cassava Sciences stock to make a market-neutral strategy. Peer analysis of Cassava Sciences could also be used in its relative valuation, which is a method of valuing Cassava Sciences by comparing valuation metrics with similar companies.

Peers

Cassava Sciences Related Equities

ANVSAnnovis Bio   3.94   
0%
42.0%
KRYSKrystal Biotech   2.47   
0%
26.0%
TGTXTG Therapeutics   1.41   
0%
15.0%
BTAIBioXcel Therapeutics   1.18   
0%
12.0%
VIRVir Biotechnology   0.60   
0%
6.0%
BIVIBiovie   0.45   
0%
4.0%
CGTXCognition Therapeutics   0.29   
0%
3.0%
VKTXViking Therapeutics   0.28   
0%
3.0%
MDGLMadrigal Pharmaceuticals   0.00   
0%
0%
AXSMAxsome Therapeutics   0.00   
0%
0%
MCRBSeres Therapeutics   0.39   
4.0%
0%
RVPHReviva Pharmaceuticals   0.56   
6.0%
0%
EXELExelixis   0.96   
10.0%
0%
CVACCureVac NV   1.91   
20.0%
0%
INMBINmune Bio   4.02   
43.0%
0%
AVXLAnavex Life   9.26   
100.0%
0%

Complementary Tools for Cassava Stock analysis

When running Cassava Sciences' price analysis, check to measure Cassava Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cassava Sciences is operating at the current time. Most of Cassava Sciences' value examination focuses on studying past and present price action to predict the probability of Cassava Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cassava Sciences' price. Additionally, you may evaluate how the addition of Cassava Sciences to your portfolios can decrease your overall portfolio volatility.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments